標(biāo)題: Titlebook: RNA Vaccines; Methods and Protocol Thomas Kramps Book 2024Latest edition The Editor(s) (if applicable) and The Author(s), under exclusive l [打印本頁] 作者: Encomium 時(shí)間: 2025-3-21 17:11
書目名稱RNA Vaccines影響因子(影響力)
書目名稱RNA Vaccines影響因子(影響力)學(xué)科排名
書目名稱RNA Vaccines網(wǎng)絡(luò)公開度
書目名稱RNA Vaccines網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱RNA Vaccines被引頻次
書目名稱RNA Vaccines被引頻次學(xué)科排名
書目名稱RNA Vaccines年度引用
書目名稱RNA Vaccines年度引用學(xué)科排名
書目名稱RNA Vaccines讀者反饋
書目名稱RNA Vaccines讀者反饋學(xué)科排名
作者: 放牧 時(shí)間: 2025-3-22 00:18
Negative-Strand RNA Virus-Vectored Vaccinesr . with special attention to Newcastle disease virus-based vaccines and their generation. It shall provide an overview on the advantages and disadvantages of certain vector platforms as well as their scopes of application, including an additional section on experimental COVID-19 vaccines.作者: 行乞 時(shí)間: 2025-3-22 01:19
Regulatory Considerations for Producing mRNA Vaccines for Clinical Trialsnew drug (IND) application. For that, several preconditions concerning production, quality control, and assurance have to be fulfilled. Here, specific requirements related to mRNA vaccines are addressed on the basis of European standards.作者: DUCE 時(shí)間: 2025-3-22 07:42
Plant Expression of ,-Encapsidated Chimeric Viral Vaccines with Animal RNA Replicons: An Updatepolyethylene glycol purification protocol is also provided to collect and purify these vaccines for immunological tests. In this update, we also provide a protocol for . co-inoculation of a modified FHV protein A, which significantly increased the yield of . chimeric viral vaccine.作者: condescend 時(shí)間: 2025-3-22 11:24 作者: 重疊 時(shí)間: 2025-3-22 15:35
Generation and Characterization of In Vitro Transcribed mRNAlecules. For the in vitro testing of the mRNA molecules, we include protocols for the transfection of various primary cell cultures and the confirmation of translation by intracellular staining and western blotting.作者: CEDE 時(shí)間: 2025-3-22 18:27
Sequence-Optimized mRNA Vaccines Against Infectious Diseasearticles. Methods described here include the synthesis, purification, and formulation of mRNA vaccines as well as a comprehensive panel of in vitro and in vivo methods for evaluation of vaccine quality and immunogenicity.作者: 頑固 時(shí)間: 2025-3-23 00:06 作者: RENAL 時(shí)間: 2025-3-23 04:51 作者: 全面 時(shí)間: 2025-3-23 07:30
Introduction to RNA Vaccines Post COVID-19,re effectively countering newly emerging pathogens, fighting currently intractable infections, or even generating novel treatment modalities for non-infectious diseases. Instead of applying protein antigen directly, RNA vaccines contain short-lived genetic information that guides the expression of p作者: 話 時(shí)間: 2025-3-23 13:23
Self-Replicating RNA Derived from the Genomes of Positive-Strand RNA Virusesd approaches to novel safe and effective vaccines. The following chapter summarizes the principles how such RNAs can be established and used for design of vaccines. Due to the large variety of strategies needed to circumvent specific pitfalls in the design of such constructs the technical details of作者: 經(jīng)典 時(shí)間: 2025-3-23 16:11 作者: Frenetic 時(shí)間: 2025-3-23 19:28 作者: packet 時(shí)間: 2025-3-24 00:58 作者: Sinus-Rhythm 時(shí)間: 2025-3-24 03:02
Generation and Characterization of In Vitro Transcribed mRNA. We then describe methods used for mRNA characterization, including UV and fluorescence spectrophotometry, as well as gel electrophoresis. Moreover, characterization of the in vitro transcribed RNA using the Bioanalyzer instrument is described, allowing a higher resolution analysis of the target mo作者: HAUNT 時(shí)間: 2025-3-24 06:59 作者: Relinquish 時(shí)間: 2025-3-24 11:34
Sequence-Optimized mRNA Vaccines Against Infectious Disease a specific panel of techniques for production and testing. Here, we describe the production of stabilized mRNA vaccines (RNActive. technology) with enhanced immunogenicity, generated using conventional nucleotides only, by introducing changes to the mRNA sequence and by formulation into lipid nanop作者: CHECK 時(shí)間: 2025-3-24 15:22 作者: 基因組 時(shí)間: 2025-3-24 20:06
Electroporation of mRNA as a Universal Technology Platform to Transfect a Variety of Primary Cells wtypes. We have spent more than two decades to optimize and adapt this method, first for antigen-loading of dendritic cells (DCs) and subsequently for T cells, B cells, bulk PBMCs, and several cell lines. In this regard, antigens were introduced, processed, and presented in context of MHC class I and作者: Conjuction 時(shí)間: 2025-3-25 02:13
A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Labn in 2018, and of the two mRNA SARS-CoV-2 vaccines, BNT162b2 and mRNA-1273 in 2021. A key to the success of these therapeutics lies in the lipid-based delivery system. The therapeutic RNAs are encapsulated in lipid nanoparticles (LNPs), which protect against enzymatic degradation and efficiently del作者: A精確的 時(shí)間: 2025-3-25 04:20 作者: TRAWL 時(shí)間: 2025-3-25 10:58
Plant Expression of ,-Encapsidated Chimeric Viral Vaccines with Animal RNA Replicons: An Updated with tobacco mosaic virus (TMV) coat protein can be fully assembled .. . cultures containing each component are inoculated together into tobacco leaves and the self-assembled hybrid chimeric viral vaccine is harvested 4?days later and purified with a simple PEG precipitation. The viral RNA deliver作者: 諂媚于性 時(shí)間: 2025-3-25 12:39
Producing Plasmid DNA Template for Clinical Grade RNA Vaccine Manufactureal to produce mRNA vaccines for clinical trials. Recently, the World Health Organization (WHO) has released regulatory guidelines related to the quality, safety, and efficacy for DNA- as well as for mRNA-based vaccines. Following an extraordinary year of scientific, regulatory, and manufacturing dev作者: 止痛藥 時(shí)間: 2025-3-25 19:17
Regulatory Considerations for Producing mRNA Vaccines for Clinical Trialsrial participant. In the EU, quality data is summarized as investigational medicinal product dossier (IMPD), in the United States, as investigational new drug (IND) application. For that, several preconditions concerning production, quality control, and assurance have to be fulfilled. Here, specific作者: agnostic 時(shí)間: 2025-3-25 22:09 作者: exigent 時(shí)間: 2025-3-26 01:56 作者: gnarled 時(shí)間: 2025-3-26 06:54 作者: aggressor 時(shí)間: 2025-3-26 11:33
Introduction to RNA Vaccines Post COVID-19, development raising high hopes for broader future application. Their mechanistic versatility promises to make them a key tool of vaccinology and immunotherapy going forward. Here, I briefly review key developments in RNA vaccines and outline the contents of this volume of Methods in Molecular Biolo作者: PLE 時(shí)間: 2025-3-26 13:25
New Generation Self-Replicating RNA Vaccines Derived from Pestivirus GenomeA and promote DC delivery. Condensing RepRNA with polyethylenimine (PEI) and encapsulating RepRNA into novel Coatsome-replicon vehicles are two approaches that have proven effective for delivery to DCs and induction of immune responses in vivo.作者: Sad570 時(shí)間: 2025-3-26 17:26 作者: incubus 時(shí)間: 2025-3-26 22:33
Production and Evaluation of Nucleoside-Modified mRNA Vaccines for Infectious Diseases because LNPs protect mRNA from rapid degradation, enabling efficient delivery and high levels of protein production for extended periods of time. Additionally, recent studies have provided evidence that certain LNPs with ionizable cationic lipids (iLNPs) possess adjuvant activity that fosters the i作者: 恩惠 時(shí)間: 2025-3-27 02:49 作者: Budget 時(shí)間: 2025-3-27 06:31 作者: OUTRE 時(shí)間: 2025-3-27 12:11 作者: 礦石 時(shí)間: 2025-3-27 13:52
Thomas Démoulins,Navapon Techakriengkrai,Thomas Ebensen,Kai Schulze,Matthias Liniger,Markus Gerber,Tions in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als978-3-642-06309-1978-3-540-27095-9Series ISSN 1611-1052 Series E-ISSN 2365-0877 作者: Ancillary 時(shí)間: 2025-3-27 21:34
ions in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als978-3-642-06309-1978-3-540-27095-9Series ISSN 1611-1052 Series E-ISSN 2365-0877 作者: 關(guān)心 時(shí)間: 2025-3-28 01:50
Cristina Poveda,Yi-Lin Chen,Ulrich Strychions in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als978-3-642-06309-1978-3-540-27095-9Series ISSN 1611-1052 Series E-ISSN 2365-0877 作者: CANDY 時(shí)間: 2025-3-28 05:39
Máté Vadovics,Hiromi Muramatsu,András Sárk?zy,Norbert Pardiions in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als978-3-642-06309-1978-3-540-27095-9Series ISSN 1611-1052 Series E-ISSN 2365-0877 作者: 雄偉 時(shí)間: 2025-3-28 09:34
Yiyang Zhou,Alison A. McCormick,Christopher M. Kearneyions in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als978-3-642-06309-1978-3-540-27095-9Series ISSN 1611-1052 Series E-ISSN 2365-0877 作者: 憤慨點(diǎn)吧 時(shí)間: 2025-3-28 11:38
ions in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als978-3-642-06309-1978-3-540-27095-9Series ISSN 1611-1052 Series E-ISSN 2365-0877 作者: parallelism 時(shí)間: 2025-3-28 14:34
, which do not contribute to the battery‘s capacity. This book presents a comprehensive study that introduces a novel concept: the development of a redox-active separator based on electrospun polypyrrole (PPy) 978-3-031-54332-6978-3-031-54330-2Series ISSN 2948-2720 Series E-ISSN 2948-2739 作者: 連累 時(shí)間: 2025-3-28 21:37
Thomas Krampsocus in previous studies has been on electrochemical inert materials as battery separators, which do not contribute to the battery‘s capacity. This book presents a comprehensive study that introduces a novel concept: the development of a redox-active separator based on electrospun polypyrrole (PPy) 作者: 擁擠前 時(shí)間: 2025-3-29 02:28
se adsorbents towards different species. This chapter focuses on studies related to the different modification processes of electrospun nanofibrous membranes to improve their selectivity and adsorption capacity for different pollutants in water treatment purposes. The classification of electrospun n作者: 潰爛 時(shí)間: 2025-3-29 06:29 作者: 音樂等 時(shí)間: 2025-3-29 10:36
Magdalena Murr,Thomas Mettenleiteral polymers can be used to produce fibers that can find potential applications in the area of biomedical, energy sensors, and filtration. The chapter summarizes the principle of centrifugal spinning, machine and material parameters and its potential application in the area of biomedical applications作者: GULF 時(shí)間: 2025-3-29 13:30 作者: 個(gè)阿姨勾引你 時(shí)間: 2025-3-29 15:42 作者: Compassionate 時(shí)間: 2025-3-29 21:28
Julia Frei,Natalia T. Jarzebska,Mark Mellett,Thomas M. Kündig,Steve Pascolo,Andreas M. Reichmuthion and operational principles as well as its maintenance. The third part covers all relevant applications in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als作者: macular-edema 時(shí)間: 2025-3-30 02:25
ion and operational principles as well as its maintenance. The third part covers all relevant applications in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als作者: labile 時(shí)間: 2025-3-30 05:12
Tatjana Sauerer,Leoni Albrecht,Nico M. Sievers,Kerstin F. Gerer,Stefanie Hoyer,Jan D?rrie,Niels Schaion and operational principles as well as its maintenance. The third part covers all relevant applications in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als作者: Nefarious 時(shí)間: 2025-3-30 10:49
Natalia T. Jarzebska,Julia Frei,Mark Mellett,Thomas M. Kündig,Steve Pascolo,Andreas M. Reichmuthion and operational principles as well as its maintenance. The third part covers all relevant applications in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als作者: AXIOM 時(shí)間: 2025-3-30 12:44
Christophe Delehedde,Ivan Ciganek,Nabila Laroui,Nathalie Rameix,Federico Perche,Chantal Pichonion and operational principles as well as its maintenance. The third part covers all relevant applications in which electrostatic accelerators are the preferred tool for accelerator-based investigations. Since some topics are common to all types of accelerators, .Electrostatic Accelerators. will als作者: irreducible 時(shí)間: 2025-3-30 18:09 作者: finite 時(shí)間: 2025-3-30 22:44 作者: 描繪 時(shí)間: 2025-3-31 04:48 作者: 鬧劇 時(shí)間: 2025-3-31 08:17 作者: Chameleon 時(shí)間: 2025-3-31 09:35 作者: 強(qiáng)行引入 時(shí)間: 2025-3-31 15:39 作者: 背景 時(shí)間: 2025-3-31 18:34
Magdalena Murr,Thomas Mettenleiterpinning has been one of the potential methods to produce fibers in the submicron range by application of high voltage. But the major limitation is the speed and ease of production. Centrifugal spinning is an alternative technique for the production of submicron fibers compared to the electrospinning作者: instate 時(shí)間: 2025-3-31 22:10
Thomas Démoulins,Navapon Techakriengkrai,Thomas Ebensen,Kai Schulze,Matthias Liniger,Markus Gerber,Trn, large particle acceleration devices. They are specifically designed for applications that require high-quality ion beams in terms of energy stability and emittance at comparatively low energies (a few MeV). Their ability to accelerate virtually any kind of ion over a continuously tunable range o
